Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep391 | Clinical case reports - Thyroid/Others | ECE2016

The importance of an intraoperative revision of all parathyroid glands, which may reveal additional pathologic changes and lead to an operation extension

Nyvltova Monika , Drbalova Karolina , Krejci Petr , Zavoral Miroslav

We present two case reports of patients who were diagnosed with hyperparathyroidism based on a parathyroid gland adenoma (PTA). The pathological parathyroid tissue was precisely localised by ultrasonography and scintigraphy before the surgery. In both cases all four parathyroid glands were revised by the surgeon resulting in an operation extension. Another parathyroid gland was removed and histologically confirmed as PTA. This surgeon’s approach was beneficial for the pat...

ea0032p551 | Endocrine tumours and neoplasia | ECE2013

Adrenal incidentalomas – a retrospective analysis for the period 2001–2011

Nyvltova Monika , Vodak Miroslav , Drbalova Karolina , Zavoral Miroslav

Introduction: With the wider availability of imaging techniques there is an increasing number of newly diagnosed, accidentally found pathological formations in the adrenal glands known as adrenal incidentaloma (AI). Currently, the professional consensus is that hormonally active incidentalomas and those suspicious of malignancy should be indicated for surgery.Methods: In our retrospective study, we analyzed data of 141 patients with a total of 160 AIs, w...

ea0032p1059 | Thyroid (non-cancer) | ECE2013

Is TSH suppression an efficient thyroid nodular goitre therapy?

Drbalova Karolina , Vodak Miroslav , Nyvltova Monika , Tuckova Inna , Hill Martin

Levothyroxine suppression therapy, i.e. keeping the TSH value below 0.3 mIU/l with the aim to reduce the total thyroidal tissue or nodule volume, is an arguable and controversial issue not only due to the effect upon nodule volume but also because of the extent of necessary suppression, the effect of incomplete suppression, long-time therapeutic effects and risk of cardiovascular problems and osteoporosis.The incidence of nodular alterations rises with a...

ea0032p1076 | Thyroid (non-cancer) | ECE2013

Use of scintigraphy in the current diagnosis of thyroid diseases

Nyvltova Monika , Vodak Miroslav , Drbalova Karolina , Zavoral Miroslav

Introduction: Scintigraphy had long been the only modality for thyroid gland imaging. With the development of other imaging techniques (sonography, CT, MRI), the role of scintigraphy has gradually diminished. However, it cannot be completely ignored, as it is the only technique to image not only the morphological structure, but also the functional status of the thyroid gland. In the current clinical practice, thyroid scintigraphy is performed with 99mTc pertechnetat...

ea0037ep940 | Thyroid (non-cancer) | ECE2015

Late onset of amiodarone-induced thyrotoxicosis causing pharmacoresistant atrial fibrillation with subsequent development of serious heart failure

Nyvltova Monika , Drbalova Karolina , Jarkovsky Patrik , Vodak Miroslav , Krejci Petr , Zavoral Miroslav

Amiodarone is a potent and among cardiologists still very popular anti-arrhythmic drug. This case report describes severe course of amiodarone-induced thyrotoxicosis (AIT) which is one of the most serious side effects of the treatment. The patient (J S born in 1950) was first hospitalised in June 2012 for atrial fibrillation with rapid ventricular response and tachycardia-induced cardiomyopathy with a decreased ejection fraction (EF). Thyroid hormones were normal at that time ...